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ABSTRACT
The behavioral depressant property of ch lordi azepoxi de (CDP)
has been traced to reduced turnover of brainstem norepinephrine.
Since tolerance to these effects develop within 5-6 administrations
of the drug, chronic administration and repeated testing provides
a means to separate the adrenergic behavioral depressant effect
from more persistent anti-anxiety or disinhibitory, or antiaggres-
slon effects which have been traced to blockade of brainstem ser-
otonin turnover and increased levels of cyclic AMP by phosphodi-
esterase inhibition.
Muricidal activity of rats is blocked by CDP. The effect is
reversed by repeated testing, by pretreatment with CDP, and by con-
comitant dosing with caffeine. This points to the adrenerglcal ly
mediated general behavioral depressant action of CDP as being re-
sponsible for its ant i -muri c i da I activity.
The attenuation of shock- i nduced fighting by CDP had previous-
ly been shown to persist despite chronic administration of the drug
and repeated testing. Thus behavioral depression is not Important
in reducing shock- 1 nduced aggression (SIA) and a role for serotonin
was suggested. However, concomitant administration of 5-hydroxy-
tryptophan, the precursor of serotonin, or «<-methyl tryptamlne, a
serotonergic receptor stimulator, did not reverse the effect of
CDP on SIA.
Iv
An alternate hypothesis suggested that phosphodiesterase
inhibition might be the property essential to the reduction of
SIA. A phosphodiesterase stimulator, Imidazole acetic acid,
which did not have any effect on SIA alone, but when administer-
ed with CDP reduced it further rather than increasing the level
of fighting. Thus a neurochemical explanation for CDP's action
on SIA Is not presently possible.
While CDP was found to reduce septal lesion-induced rage,
pretreatment before lesioning did not seem to alter the effective-
ness of the drug. Thus it seems that the attenuation of septal
rage is neither dependent on the adrenergical ly mediated behavioral
depressant effect of CDP nor could any serotonergic mechanism be
reliably related to the effect. A more specific ant i
-aggress ion
effect is suspected.
v.
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Chlordlazepoxide (CDP) has for many years been known to have
a profound effect on aggressive behavior (Randall, 1960; 1961).
The effects of CDP as well as the other benzodiazepines have been
extensively examined In a variety of aggressive paradigms. CDP
was found to depress mouse killing in rats (Lolselle and Caparrel,
1966), to have taming effects on vicious cynomolgus monkeys
(Helse and Boff, 1961), to produce "calming" of septal lesion-
Induced rage (Horovitz et a I., 1963), to reduce shock-induced
aggression of mice (Tedeschi et al., 1959), and to reduce fight-
ing of previously isolated mice (Cole and Wolf, 1966). Although
a reduction in various aggressive behaviors occurs under many
conditions, the results of a number of experiments are contradic-
tory. For example, several authors have found that CDP causes
an increase in spontaneous aggression In grouped male mice (Fox
and Snyder, 1969; Fox, Tockosh, and Wilcox, 1970). Reports on
the effect of benzodiazepines on hostile-aggressive behavior in
humans also contain contradictory results. While a number of
experimenters report a reduction In various aggressive behaviors
(Gleser et al., 1965; Podobnikar, 1971), others report an Increase
In overtly hostile behaviors (DiMascio et al., 1969; Salzman et al.
1969). This Increase In aggression In the clinical setting is
most often attributed to the release of behaviors previously under
avers I ve control
.
2Examination of the literature suggests that there are several
variables which may explain the discrepancies in experimental re-
sults. First, the species examined may be a significant factor
in the determination of ant i
-aggressive effects of the benzodiaze-
pines. Species variations have been demonstrated not only be-
havioral ly but neurophysiological differences in response to ben-
zodiazepine administration have also been reported (Nagy and
Desci
,
1973). Second, the dose of the drug and the route of ad-
ministration clearly have an effect upon the efficacy of the drug
in altering aggression (Christmas and Maxwell, 1970). Third and
perhaps most important is the aggression paradigm used. It is
generally assumed that various testing situations elicit differ-
ent aggressive behaviors having different underlying physiological
substrates (Moyer, 1968). If this indeed is the case, then it
should not be surprising that different drugs are effective in
altering different aggressive behaviors, or that the same drug is
not equally effective in reducing the various forms of aggression.
Finally, the duration of treatment with the benzodiazepines, i.e.,
acute vs. chronic administration, is an important factor in the
effect of the drugs on aggression (Fox et al., 1970; DiMascio, 1973).
Of considerable importance in evaluating the effectiveness of
the benzodiazepines in reducing aggression is the fact that they
cause some general behavioral depression. Previously the determin-
ation of the role of behavioral depression in the reduction of
aggression has led to ambiguous results. For instance, Horovitz
et al. (1965) found a reduction in mouse killing in rats after
treatment with CDP but only at doses which impaired locomotor
ability. In most cases in order to deal with this problem an in-
dex of the effective dose (ED50) at which aggression was reduced
was compared to the effective dose at which locomotor ability was
impaired. The determination of the ED50 of locomotor impairment,
however, varies significantly among laboratories and for this
reason may represent a major variable in the estimation of the
significance of behavioral depression to the reduction in aggres-
sive behavior.
A more effective way of identifying the contribution of be-
havioral depression to the attenuation of aggression Is to allow
a tolerance to the behavioral depressant effect to develop over
several days of administration of the drug. This technique is
based on the finding of Stein et al. (1975) who demonstrated that
the behavioral depressant effect of oxazepam, a drug in the ben-
zodiazepine class, is correlated with the reduction of NE turn-
over In the midbraln-hlndbrain region of the rat, an effect pre-
viously reported for all brain regions except the medulla-pons
region by Taylor and Laverty (1969) and Corrodi et al. (1971).
Both the change in NE turnover and the general depression of be-
havior as measured in the Ge I ler-Sei f ter test, disappeared after
5-6 dally administrations of the drug. Therefore, the technique
of repeated administration of the drug eliminates the necessity to
determine the level of behavioral depression by using a measure
such as locomotor ability which may be quite unrelated to the ag-
gression paradigm used.
A second significant behavioral effect of benzodiazepine ad-
ministration is an increase in behaviors under aversive control.
This potent "ant i -anxiety" effect has been demonstrated In a num-
ber of paradigms (Feldman and Green, 1967; Feldman, 1968; Cook and
Kelleher, 1962; Geller, Kulak and Selfter, 1962; Feldman, Kaada,
and Langfeldt, 1973; and others) and In each case, the drug seems
to have reduced the significance of punishment as demonstrated by
an Increase In responding under conditions of negative reinforce-
ment. Stein et al. (1973) has shown that the anti-anxiety effect
of oxazepam Is correlated with the significant reduction In 5HT
turnover, an effect found by Chase et al. (1970) after administra-
tion of diazepam, a congener of CDP. Neither the potent anti-
anxiety actions of the drug nor the reduced 5HT turnover seem to
undergo tolerance with repeated administration of the drug.
From the foregoing discussion it seems that the most effec-
tive way to measure the contribution of behavioral depression to
the decrease in aggression is to use chronic administration and
repeated testing. This method would allow the examination of the
Initial effectiveness of the drug as well as changes in effective-
ness as tolerance to the behavioral depressant effect develops.
It follows, first, that any ant i -aggress ion effects of benzodiaze-
pines that diminish or disappear with repeated testing are
probably due to the alteration of an adrenergic mechanism. Second,
the persistence of an ant i
-aggress i ve effect during repeated ad-
ministration of the drug would give strong support for the involve-
ment of a serotonergic mechanism.
Experiment 1
While mouse killing by rats is one of the aggressive behaviors
that has been suppressed by CDP, recently Wnek et al. (1974) in-
duced an increase in mouse killing in rats treated with low doses
of CDP. However, even in cases where higher doses of CDP were used
and mouse killing was attenuated, the importance of the behavioral
depressant effect for the reduction of aggression is not clear.
Horovitz and his co-workers (1965, 1966) and Karl i (1961) determined
that mouse killing is diminished by benzodiazepines only at doses
that produce ataxia. These studies, however, determined the drug
effect only after acute administration. Therefore, differences in
the determination of the role of behavioral depression on muricide
activity may once again only have reflected differences in methods
of measuring behavioral depression.
The following experiments have determined the effects of
dally treatment with CDP on mouse killing In rats in an attempt to
resolve the discrepancies previously described and to determine
the role of behavioral depression in CDP's effect on mouse killing.
It was hypothesized, on the one hand, that If behavioral depression
plays a significant part in the reduction of mouse killing, the
frequency of killing should be lowest, or the latency to kill mice
should be highest during initial drug tests. Then as testing con-
tinues the killing frequency should increase and killing latency
should decrease as the tolerance to the behavioral depressant effect
gradually develops. On the other hand, if there were an anti-
murlclde factor independent of behavioral depression, then the fre-
quency of mouse killing should remain low or the latencies of mouse
killing should be high for the duration of the drug tests.
If tolerance to a CDP-induced anti-murici de effect were found,
it would also be of interest to measure the duration of the tol-
erance effect. Ideally, the duration of tolerance would involve
comparisons among groups that would be retested with the drug after
different time intervals of drug abstinence. However, the difficulty
of obtaining large numbers of muricidal subjects which would be
necessary for such tests precluded this procedure. Instead, sub-
jects in our experiments were retested for the effect of CDP on
muricide after a number of different time intervals of drug abstin-
ence. The complication here is the possibility that a series of
drug tests might contribute to the duration of the tolerance effect.
Nevertheless, this procedure was carried out because it would at
least provide an initial estimate of the duration of tolerance.
7Method
The subjects in the first experiment were 10 male Sprague-
Dawley rats 4-6 months old and weighing 350-475 g. They were
housed Individually and fed and watered
_ad libitum
. The animals
were maintained on a 12 hour alternating light-dark cycle with
light from 7 P.M. to 7 A.M. throughout the experiment. These
animals quickly and reliably killed mice placed in their home
cages prior to any drug treatment. During each test session a
live mouse was placed in the living cage of each rat and the
latency to kill the mouse was recorded. If the mouse was not kill-
ed within 15 minutes it was removed from the cage. Mice killed
during the session were removed promptly from the cage to prevent
the rat from eating it. After three daily no-drug muricide tests,
each rat received 50 mg/kg CDP i.p. 30 minutes before 8 successive
daily muricide tests.
Following the eight consecutive tests each rat was retested
for muricide activity under drug conditions after 7 days of neither
drug administration nor muricide testing. Then another drug test
was given after an additional 14 days; and a final test after 26
additional days.
Results and Discussion
Three of the 10 subjects were removed from the analysis of
the results. Two of the 3 rats never seemed to be affected by
8the drug and killed rr.ice consistently with a low latency through-
out the drug tests. The third animal appeared to be severely de-
pressed and this behavioral depression persisted throughout the
8 days of drug administration with no murlclde activity. These
animals were eliminated from the analysis because their response
to the drug was clearly aberrant since it was consistent throughout
the testing procedure and could not be due to procedural variation.
Moreover, the addition of this data for the most part adds a con-
stant to the measurement of murlclde and latency since their re-
sponding Is relatively stable over the 8 days of drug treatment.
Finally, adding these subjects does not alter the significance level
of the overall findings.
The results of the remaining animals are shown in Fig. 1. It
is clear from the figure that the initial administration of CDP on
Day 4 significantly reduced the number of killing responses. Al-
though two of the 7 animals represented did kill mice on the first
day of drug administration, both of these animals were non-killers
on the second day. It can also be seen that the number of kills
increases over successive days under drug conditions and that by
Day 10, all animals are again killing mice placed In their home
cages. The one non-killer on Day 11 appeared sick and died two days
later.
The latency of mouse-killing Is shown In Fig. 2. Non-killers
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Figure 2. Latency of muricidal activity under no drug
(saline) and drug (CDP) conditions. Non-murici dal
rats were assigned a Jatency of 15 min. The vert-
ical bars through the data points indicate the
standard error of the mean.
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were assigned the maximum latency of 15 minutes. A t-test for pair-
ed Observations showed that there is a significant increase in lat-
ency on Day 4 (the first Drug day) as compared to the last No-drug
test day (Day 3) (t= 4.04, p<.01). Comparison of the mean latencies
for the first 4 drug days with the last 4 drug days also shows a
significant difference (t= 3.53, p<.02). However, the difference
In latency between Day 3 (the last No-drug day), and Day 11 (the
eighth Drug day) was not significant. These results clearly show
suppression of mouse killing by rats after initial treatment with
CDP, but there also was a gradual increase in killing and a de-
crease in latency with repeated administrations of the drug. This
strongly suggests that the behavioral depressant effect of the drug,
which usually shows a tolerance after repeated doses, is the signif-
icant factor that reduces mouse killing. Examination of the data of
individual animals show that each animal developed tolerance to the
effect of the drug at a different rate and this difference accounts
for the variance at each data point in Fig. 2. Two of the 7 subjects
returned to killing mice after only one drug administration. Three
of the 7 did not return to killing until after receiving drug on
3 consecutive days. One subject did not kill for 4 drug-test sessions
and one subject showed an absence of mouse killing behavior for
6 out of the 8 drug tests.
A discussion of the data concerning the duration of tolerance
will be postponed until the discussion of Experiment 2 since subjects
from both experiments were used.
12
Experiment 2
Drug tolerance to the behavioral depressant effect in these
experiments is either physiological or behavioral. With respect
to a physiological tolerance, there Is a drug disposition tolerance
which is caused by an increased rate of elimination or deactivation
of the drug. There is also a pharmacodynamic tolerance in which
neural tissue apparently returns to normal function In spite of con-
tinuing high plasma levels of the drug. This reaction Is character-
istic of morphine tolerance (Jaffe, 1970). Behavioral tolerance Is
characterized as an acquired accommodation to the drug probably
through learning experiences and a return to normal functioning
(Dews, 1962). There was the possibility that the tolerance that
occurred in Experiment 1 was the behavioral type and was merely a
manifestation of the animals' acquired ability to kill mice in the
presence of the drug. To Investigate that possibility muricidal
rats were given CDP daily for a number of days, then tested for mur-
iclde for one day under drug conditions. It was hypothesized on
the one hand that if the animals In this experiment would show un-
diminished muricidal activity on the drug-test days, this would ar-
gue for a drug disposition or pharmacodynamic tolerance. On the
other hand, since these rats would have had no opportunity to learn
to kill mice under the influence of CDP and If they were suppressed
by the drug and no muricide occurred, this would argue for a behavior-
al tolerance in Experiment 1.
Method
Nine male Sprague-Daw ley rats from 5-7 months old and weighing
375-500 g. were used as subjects. Each of the rats used consistent-
ly killed mice placed in his home cage. On days 1-3 each rat was
given a saline injection followed 30 min later with a muricide test
as described In Experiment 1. On days 4-10, each rat was given 50
mg/kg I. p. CDP, but no muricide tests were given. On day 11, each
rat was given the usual CDP dose followed 30 min later by a muri-
Ciide test. Latency to ki I I the mouse was recorded. A maximum of
15 minutes was allowed for each test. As in Experiment 1, these
'
animals were also tested after an interval of 7, 14 and 26 days to
get an estimate of the duration of the tolerance.
A control group of 6 mouse killers were tested with saline in-
st^ead of CDP on days 4-10 and then tested with CDP (50 mg/kg) on
day 11. This was done to eliminate the possibility that the inter-
val without mouse killing after the first 3 day period of mouse kill
Ing had In itself an effect on muricide on day 11.
Results and Discussion
The results of Experiment 2 were that the 9 subjects that kill-
ed mice on- the first 3 no-drug test days also killed mice
during the muricide test under drug conditions (day 11). A compar-
ison of the average latency to kill on the third no-drug day and
the drug-test day (day 11) also showed no significant difference.
These data, along with subjective observation of the activity of
these chronically dosed subjects in response to the presentation
of the mouse on day 11 strongly suggests that tolerance to the be-
havioral depressant effect of the drug had developed during the
daily administration of the drug. These observations are con-
sistent with the findings of Hoogland et al. (1966), Goldberg et
al. (1967) and Margules and Stein (1968). Also, the high rate of
mouse killing among these chronically dosed rats indicates that
there is probably no specific antl-murl ci dal effect of CDP, and
the Initial suppression of this form of aggression in Experiment 1
was due to general behavioral depression. Furthermore, the fact
that all the subjects killed on their first test day under the
drug condition eliminates the possibility that the rats In Experi-
ment 1 had acquired a behavioral tolerance and merely needed prac-
tice under the drug state to again become consistent killers.
The 6 rats In the control group first killed mice in muricide
tests for 3 days. They were then given saline on days 4-10, and
CDP and a muricide test on day 11. On the drug-test day 4 rats
did not kill at all during the 15 minute test, and 2 killed after
relatively long latencies, 70 and 90 seconds. Assigning a latency
of 15 minutes to the non-killers, a t-test for paired observations
showed that the latency difference between day 11 for the control
and experimental groups were also significant (t= 4.33, p-'^^.OI).
This result shows that the no drug-no test Interval (days 4-10) did
not itself increase the probability of muricide on drug day 11,
and that the sole determinant of mouse killing on drug day 11 was
whether or not drug was given on days 4-10.
Finally, as in Experiment 1 the chronically dosed animals in
Experiment 2 were also given a drug-muri ci de test after 7, 14, and
26 day intervals. Combining the results of these two groups, mur-
icide latency after each of these 3 intervals was compared with the
latency for the third no-drug test day and the last drug test day
of Experiment 1. No significant difference was detected in each
comparison after 7 days of drug abstinence. Fourteen days after
that, a t-test for paired observations showed that the differences
in both comparisons were significant (t= 2.38, p<.05; t= 2.17,
p <.05) as were the differences after a further interval of 26
days (t= 6.75, p<.001; t= 6.48, p^.001). This data suggests that
the tolerance to the behavioral depressant effect of CDP lasts for
at least a week and is lost sometime in the next 2 weeks of drug,
abstinence when tested in this manner.
Experiment 3
In order to further support the earlier finding that behavior-
al depression is the significant factor in reducing mouse killing
with CDP, a CNS stimulant was used to antagonize the behavioral
depressant effect of CDP. Caffeine has previous, ly. been found to
16
effectively counteract the behavioral depressive effect of CDP on
spontaneous activity (Quenzer et al., 1974). Also caffeine has been
shown to have no effect itself on muricide (Sofia, 1969).
Method
Ten male albino rats (5 Sprague Dawley and 5 Holtzman), approx-
imately 6 months old and weiighing 400-500 g. served as subjects.
Each of the rats was a reliable mouse killer when tested for several
days In his home cage under no drug conditions. They were housed
separately and fed and watered ad libitum
. Each subject was given
murlclde tests for a total of 6 days in the manner described in Ex-
periment 1. However, saline (.0.9%, 1 cc/kg i.p.) was administered
30 mln before testing on Days 1 and 2, caffeine (75 mg/kg) on Days
3 and 4, and CDP (50 mg/kg) plus caffeine (75 mg/kg) on Days 5 and 6.
Results and Discussion
The data for the 2 strains of animals were grouped because
there were no differences in frequency, latency or drug effects
between them. All subjects killed mice within 15 min on each of
6 tests whether they were administered saline, or caffeine, or
caffeine plus CDP. This result markedly contrasts the almost com-
plete suppression of mouse killing after initial tests with 50 mg/kg
CDP In Experiment 1. However, a comparison of the latencies of
mouse killing showed that on Days 5 and 6 (CDP plus caffeine) lat-
encies were longer than those on Days 1 and 2 (saline). The mean
values were 52.0 and 11.4 seconds for the drugged and saline test
respectively. A t-test for paired observations showed that this
difference was significant (t= 2.60, p<.05). But a Student t-
test showed that a comparison of the average latencies for the first
two days of CDP administration in Experiment 1 with latencies on
Days 5 and 6 in Experiment 3 produced a highly significant differ-
ence in latency of muricide (t= 6.88, p<.001). The mean values
were 52.0 and 636.8 seconds for the latencies in Experiment 3 and
1 respectively. This shows that the concommitant addition of caf-
feine strongly affected the ant i -muri cl de effect of CDP, but in
the doses used, the CDP effect was not completely antagonized by
caffeine. Our observations were that the rats made numerous at-
tempts to catch the mice but showed a degree of incoordination that
often delayed the kill. Caffeine administered on Days 3 and 4 did
not noticeably interfere with muricidal activity.
General DIsscussion
In the present experiments, repeated testing with CDP alter-
ed the effect of the drug on mouse killing. The fact that the rats
resumed muricidal activity under large doses of CDP suggests that
the adrenergical ly mediated behavioral depressant effect of CDP
was responsible for the non-specific initial suppression of muri-
cide. The antagonism of the ant i -muri ci de effect by caffeine,
which is known to reverse the behavioral depressant effect of CDP
in an activity box, provides further support for this hypothesis.
W- is also known that the xanthines and the catecholamines in-
crease peripheral concentrations of cAMP (Ritchie, 1966). It
follows that the caffeine-induced increase in cAMP would reverse
the possible reduction of cAMP brought about by a CDP-induced de-
crease in catecholamine turnover. This argument lends credence
to the notion that the adrenergic behavioral depressant effect is
antagonized by caffeine.
A number of muricide experiments manipulating brain levels of
5HT indicate a role for this amine as well. Both Sheard (1969)
and DiChiara et al. (1971) showed that the blockade of 5HT synthe-
sis with pCPA is followed by muricide behavior in rats that pre-
viously did not kill mice. Grant et al. (1973) showed that after
dorsal and median raphe lesions, when the forebrain content of
5HT was approximately 10% below normal, rats showed increased fre-
quency and decreased latency for lethal attacks on mice. The time
course of this behavioral effect paralleled the reduction in fore-
brain 5HT suggesting that 5HT exerts inhibitory control over mouse
ki I I ing. Further support for the inhibitory effect of 5HT is pre-
sented by Kulkarni (1968) who found a significant suppression of
mouse killing in rats pretreated with 5HTP. Our results are also
compatible with the notion that 5HT has an inhibitory effect on
mouse killing. CDP blocks 5HT turnover as well as reducing NE
turnover, and this reduction In 5HT activity may actually increase
muricide. This latter effect, however, is masked by CDP-induced
behavioral depression and emerges only after tolerance to this ad-
renergic, murici de-suppressant effect occurs. Thus our conclusion
is that the balance between NE and 5HT may be the significant fac-
tor In determining the level of mouse killing. This idea may ac-
count for some anomolous effects of CDP that were found when pro-
tocols of individual rats were examined. Grouping the results of
Individual rats showed a steady increase in muricide activity dur-
ing consecutive drug tests as seen in Fig. 1. However, some ani-
mals fluctuated between killing and not killing during early drug
tests. This may be due to a delicate balance between the depres-
sant action of CDP mediated by lowered adrenergic activity and a
muricide stimulant action mediated by lowered serotonergic activity.
20
PART
The technique of chronic administration of CDP with repeated
testing was formerly used in the shock- 1 nduced aggression (SIA) par-
adigm (Quenzer et al., 1974). In those experiments it .as found
that CDP suppressed SIA and repeated testing had no further effect.
Thus, It Is fafrly clear that the CDP-lnduced change in NE turn-
over and the correlated behavioral depression was not responsible
for the decrease In SIA since tolerance to behavioral depression,
with the restoration of normal turnover rates of NE, was not ac-
'
companled by Increased fighting. A more likely alternative Is that
the CDP-lnduced reduction in 5HT turnover, for which no tolerance
seems to occur was responsible for the decrease In this type of
aggression. This alternative hypothesis, however, must be weigh-
ed in light of other evidence presented by Eichelman and his co-
workers (1972a, 1972b, 1972c) who suggested an inhibitory role
for NE in this type of aggression. They found that depletion of
brain NE with either 6-hydroxydopami ne or 6-hydroxydopa significant-
ly increased the amount of SIA without altering jump thresholds to
electric shock, and that the Increase in attack over time seemed
to be correlated with the time course of adrenergic nerve termin-
al degeneration. However, at least In some cases 5HT was also
significantly reduced (Eichelman et al., 1972a).. Thus, in some
ways we have examined the possibility that the reduction in SIA
following CDP administration is related to the reduction in 5HT
turnover induced by the drug.
In order to test this hypothesis a serotonergic agonist which
Increases neural activity in serotonergic neurons was used to an-
tagonize the CDP-induced attenuation of SIA. The restoration of
brain levels of 5HT by 5HTP, the biologic precursor of 5HT, after
depletion with such agents as pCPA has been well documented (Geller
and Blum, 1970; Tenen, 1967) and is a technique commonly employed
to substantiate the efficacy of serotonergic depletion on behavior.
Thus, the CDP-induced reduction in 5HT turnover may be reversed by
concomitant administration of 5HTP although an increase in the
levels of the amine does not necessarily imply an increase in
utilization. With this technique several other potential problems
have been identified (Tenen, 1967). One such problem Is that al-
though 5HT levels of total brain are returned to within the normal
range, regional distribution of 5HT might be quite different from
normal. Also, the distribution and amount of "bound" and "free"
5HT might be quite different. Finally, even if distribution were
restored to normal, the sudden, rapid increase in 5HT at those sites
that have had reduced serotonergic activity for several days might
result in different functional effects than normal, such as a
pharmacologically induced denervation supersensitivity.
Further, if the CDP reduction in turnover were due to a de-
crease In the release of 5HT rather than in the rate of synthesis.
then increasing endogenous levels of transmitter with administration
of 5HTP may not reverse the physiological effect of CDP nor its
effect on SI A. In this case a 5HT agonist such as K-methyl trypt-
amlne which directly stimulates post-synaptic receptor sites, would
more readily reverse the CDP effect. It should be mentioned that
earlier attempts to change the behavior of pigeons on multiple food
and punishment schedules using <?C-methyl tryptamine have not been
entirely successful (Graeff and Schoenfeld, 1970). They found a
reduction in most behaviors examined, but only at doses that pro-
duced "gross behavioral changes" such as a refusal of food, mark-
ed tremors and diarrhea. Also, an attempt to reverse the CDP-
induced facilitation of two-way avoidance with varied doses of
«<-methyl tryptamine did not proved to be successful (Espino, 1974).
Nevertheless, an antagonism of the CDP-induced reduction of SIA
by either concomitant 5HTP or^^-methyl tryptamine administration
could indicate a role for 5HT in SIA.
Experiment 1
The subjects were 48 male Sprague Dawley rats approximately
5 months old, weighing between 350-400 g. They were paired ac-
cording to body weight at the start of the experiment. They were
housed individually and fed and watered ad I i b i turn .
The apparatus used was a modification of that used by Ulrich
and Azrin (1962) and has been described elsewhere (Quenzer et al.,
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1974). Each test session consisted of the presentation of 100
2 mA. shocks of i-sec duration applied through the grid floor every
2 seconds. The number of characteristic fighting responses made
by each pair of rats was recorded. Each pair of subjects was test-
ed for 9 days after 3 initial priming sessions. On days 1-3 each
subject received a saline injection (0.9% saline, 1 cc/kg) 30 min
before testing. On days 4-6, 15 mg/kg CDP was administered to
each subject 30 min before testing. The pre-test drug treatment
on days 7-9 was 15 mg/kg CDP p I us 15 mg/kg 5HTP for Group 1 and
15 mg/kg plus 30 mg/kg 5HTP for Group 2. Group 3 received 6 mg/kg
*^-methy| tryptamine plus 15 mg/kg CDP on days 7-9 and on days
10-12 pretest treatment consisted only of 6 mg/kg <<-methy I trypt-
amine. For the last two days this group received only saline be-
fore testing.
It was hypothesized that if the CDP- induced reduction in SI A
Is due to a decrease in 5HT turnover, then concomitant treatment
with 5HTP or«<-methyl tryptamine should return the number of
fighting responses to control levels. However, if no change in
the aggression level Is determined, it Is likely that some effect
of CDP other than that of altering 5HT turnover is responsible for
the reduction In SI A. Moreover, if CDP effects are not reversed
by 5HTP but are reversed byX-methyl tryptamine, it strongly sug-
gests that CDP blocks turnover of 5HT at some point other than at
synthes I s
.
Results and Discussion
The results of Experiment 1 are illustrated in Fig. 3. A
t-test for paired observations showed that CDP signf f icantly re-
duced SIA in Groups 1 and 2 respectively (t= 6.28, p-^.OOl;
t= 3.82, p<.01) confirming earlier studies (Quenzer et al., 1974).
Clearly, neither dose of 5HTP administered concomitantly significant-
ly reversed the CDP-induced attenuation of SIA. However, despite
the fact that numerous experimenters, report behavioral effects at
these doses, it has been suggested that the drug may not be reach-
ing the brain due to rapid peripheral
-decarboxylation to 5HT (Cook,
personal communication). While it may be desirable to reexamine
the effects of 5HTP on the CDP-induced attenuation of SIA in the
presence of a peripheral L-aromatic amino acid decarboxylase in-
hibitor, the additional drug-behavior interactions and the attendent
difficulties in identifying the neurochemical effects of the new
drug combination would make the results of this procedure subject
to considerable speculation.
Figure 4 shows the amount of shock-induced fighting for Group
3 which was treated with <<-methyl tryptamine. An analysis of
variance detected a significant difference in the amount of fight-
ing after the various drug treatments (F= 34.60, p<.01). A t-test
for paired observations of the first 3 saline treatment days as
compared to the last 2 saline treatment days showed no significant
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difference suggesting that prolonged periods of dally testing and
multiple drug treatments probably did not have any effect on the
base rate of fighting.
A Newman Keul's test of contrasts demonstrated that CDP
significantly reduced SI A as compared to saline treatment (p<.01).
The fighting score after the combined treatment of CDP plus <A-
methyl tryptamine also was significantly different from saline
alone (p <01) as well as from both the CDP alone treatment (p<.01)
and the
-methyl tryptamine alone treatment (p<.01). Finally,
the number of fighting responses afters-methyl tryptamine alone
was significantly different from baseline (saline) levels (p^.Ol).
These data show that while CDP alone significantly reduced shock-
Induced fighting, this attenuation of aggression is not antagonized
by the serotonergic agonist,
-methyl tryptamine; rather, there
was an additive effect.
Why *<-methyl tryptamine should itself reduce SI A and further
reduce SIA already diminished by CDP is not clear. Although the
dose of the drug used was quite high, none of the "gross behavioral
changes" described by Graeff and Schoenfeld (1970) for pigeons
were evident. Further, rats given similar doses and tested in a
2-way avoidance paradigm did not in any way impair performance nor
reverse CDP facilitation of acquisition of avoidance responses
(Espino, 1974). These results, in combination with the inability
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to detect significant effects of 5HTP on the reduction of SIA by
CDP as shown in Groups 1 and 2, suggest that a serotonergic mechan-
ism may not be central to the CDP-induced attenuation of SIA.
Such a conclusion supports the findings of Connor et al. (1970)
who found that 5HT depletion with pCPA had no effect on the level
of SIA.
Experiment 2
An alternative mechanism by which CDP may attenuate SIA is by
Inhibiting cAMP phosphodiesterase. The finding by Quenzer et al. "
(1974) that caffeine as well as CDP alone reduce SIA and in combin-
ation had an additive effect, further suggests that a property
held in common by caffeine and CDP, i.e. cAMP phosphodiesterase
Inhibition, may be responsible for the decrease in SIA. Inhibition
of phosphodiesterase, the enzyme responsible for the degradation
of cAMP to 5 'AMP, produces an increase in the level of endogenous
cAMP. Cyclic AMP has been identified as the mediator of numerous
hormonal responses, and as having a role as a "second messenger"
In synaptic transmission (Rail and Gillman, 1971; Kebabian and
Greengard, 1971; McAfee and Greengard, 1972).
It has been known for some time that caffeine and other drugs
In its cl-ass, the methy I xanth i nes , are potent phosphodiesterase
Inhibitors (Robison et al., 1971). Recently the same property has
been Identified In vitro for CDP as well (Beer et a I., 1972;
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Crowley et a I
. ,
1974). Beer et al. (1972) further showed that
this effect was correlated with anti-anxiety properties of the
substances during behavioral testing. Also, antagonism of the
CDP-induced anti-anxiety effect has been demonstrated by stimulat-
ing phosphodiesterase with imidazole acetic acid (IMA) a naturally
occurring metabo I ite of histamine (Horovitz et al., 1972). Imid-
azole acetic acid selectively increases phosphodiesterase activity
fn brain, kidney, intestine and liver but not in heart or skeletal
muscle (Roberts and Simonsen, 1970).
In order to test the hypothesis that CDP-induced phosphodiester-
ase inhibition may be responsible for attenuating SIA, IMA was con-
comitantly administered with CDP with the expectation that IMA would
stimulate phosphodiesterase activity and the CDP-induced reduction
of SIA would be reversed. Further, assuming a common mechanism,
caffeine's attenuation of SIA should also be reversed by IMA.
Method
The subjects were 24 male Sprague Dawley rats from 6-8 months
of age. They weighed between 375-450 g. at the start of the ex-
periment and were paired according to body weight. They were
housed individually and fed lab chow and watered ad lib .
The apparatus and testing procedure was the same as that used
In Experiment 1. Five pairs of subjects were first tested for
SIA on 3 initial daily priming sessions. Subsequently, on days 1-3
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each subject received an l.p, saline injection (0.9^ saline, 1 cc/kg)
30 min before testing. On days 4-6, 15 mg/kg CDP i.p. was administer-
ed 30 min before testing. The drug treatment on days 7-9 was 125
mg/lig IMA i.p.
1 hour before and 15 mg/kg CDP 30 min before SIA test-
ing. The dose and time parameter?- were suggested by Beer (1974, per-
sonal communication). IMA alone was the pretest drug treatment ad-
ministered 1 hour before SIA testing on days 10-12. To examine the
possibility that repeated testing may in itself alter the number
of fighting responses, the Ss were again tested under saline con-
ditions for 3 days (Days 13-15) after the imidazole alone treat- '
ment. The injected volume was the same for saline and drugs.
The SIA testing procedure was the same for 7 pairs in Group 2.
However, following three saline test days, these subjects received
on days 4-6, 50 mg/kg caffeine benzoate i.p. 30 min before testing.
On days 7-9 the pre-test drug treatment included 125 mg/kg IMA
1 hour before and 50 mg/kg caffeine 30 min before testing. On days
10-12 each subject received 50 mg/kg caffeine plus 250 mg/kg IMA.
Results
The results are shown on the left in Fig. 5. A within subjects'
analysis of variance of the data for Experiment 1 showed a signif-
icant effect for treatments (F= 37.10, p'<^.005). There was no sig-
nificant change over days within treatments; nor was there an in-
teraction between the various treatments and days of testing within
each treatment.
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Figure 5. Comparison of the number of fighting responses
under saline and drug conditions. Vertical
bars represent the standard deviation.
A Newman Keul's test of contrasts for group 1 showed that the
number of fighting responses after IMA alone was not different from
the number of fighting responses after either of the saline pre-
treatrrents. After the CDP treatment, the amount of fighting was
significantly less than that after saline (p<.on. The combined
treatment, CDP + IMA, similarly produced a significant reduction
as compared to saline (p<01) as well as compared to the CDP alone
treatment (p<.01).
The results for group 2 are shown on the right in Fig, 5.
Analysis of the data for group 2 again showed a significant effect
of treatment (F= 27.23, p<01) as well as a days effect within
treatments (F= 6.72, p<.05). An analysis of daily effects showed
this latter effect probably is due to an initial depression of the
fighting rate each time a new caffeine treatment was administered;
then the rate increased slightly and leveled off over the second
and third days of each treatment. Why this effect occurred with
caffeine and did not with CDP is not known.
A Newman Keul's test of contrasts for group 2 showed that caf-
feine significantly reduced the number of fighting responses as
compared to saline days (p^.01). The aggression scores after caf-
feine and IMA were also different from saline pretreatment days
(pCOl). However, the amount of fighting after caffeine plus IMA
as compared to caffeine alone was not significantly different.
The final test with 50 mg/kg caffeine and 250 mg/kg of IMA
was done in an attempt to find an effective dose of IMA to inter-
act with caffeine. This drug combination led to a further re-
duction in SIA. However, prior to SIA tests these animals showed
signs of catalepsy; they could be placed in awkward positions with-
out resistance and remained so without restraint. Despite this
effect their response to grid shock did not seem impaired, but
because of the suspicion of catalepsy, this test was not included
in the statistical analysis.
Di scuss ion
The significant findings of this investigation were that the
phosphodiesterase stimulator, IMA, had no effect by itself yet it
potentiated the effect of CDP on SIA rather than antagonizing it.
Also, IMA had virtually no effect on caf fe i ne- i nduced reduction
of SIA. Therefore, it would seem that the anti-SIA properties of
CDP and caffeine are not related to their ability to Inhibit phos-
phodiesterase.
The fact that IMA itself produced no change in the level of
SIA but potentiated the CDP-induced reduction of SIA suggests that
there may be a competition at some point in the metabolic degrada-
tion of these substances. That is, IMA may compete for the
enzymes that metabolize CDP, thereby raising plasma levels of the
parent drug or its many active metabolites and potentiating their
effects. The measurement of plasma levels and rate of degradation
of CDP in the presence of IMA should answer this question. How-
ever, this hypothesis is weakened somewhat by the fact that 15 mg/kg
CDP yielded a level of suppression of SIA that could not be increas-
ed by doubling the dose (Quenzer et al., 1974), which presumably
would also raise plasma levels. Consequently any increase in plasma
levels of CDP would not be expected to be more effective.
With respect to caffeine, the fact that IMA does not potenti-
ate the anti-aggression effect of this drug suggests that the met-
abolic pathways for IMA and caffeine are different. This hypothesis
is still consistent with the finding that caffeine and CDP have
additive effects in suppressing SIA.
Finally, the possibility must be considered that the in vitro
findings of phosphodiesterase stimulation by IMA (Roberts and
Simonsen, 1970), may not be applicable to In vivo conditions.
General Discussion
Considering the results of Experiments 1 and 2 together, it is
clear that we have not yet elucidated the neurochemical mechanism
by which CDP and caffeine reduce shock- 1 nduced fighting in rats.
Our previous work using repeated administration of CDP and testing,
suggested that the decrease In SIA is not related to the reduction
in NE turnover. Failure toantagonize the CDP-induced reduction in
SIA with either 5HTP or^7<^-methy I tryptamine casts considerable
doubt on the hypothesis that the reduced 5HT turnover after CDP Is
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the neurochemical event responsible for the attenuation of shock-
Induced fighting. Finally, Experiment 2 raises a considerable
question about the importance of phosphodiesterase inhibition as
a mechanism responsible for the reduction of shock-induced fighting
by CDP.
No current hypothesis of neurochemical action of CDP presents
a plausible explanation for the redo<rtion of SIA by the drug. How-
ever, Lidbrink and Farnebo (1973) suggest that the reduced amine
turnover induced by CDP may be due to a reduction in the flow of
nerve impulses, rather than altering synaptic activities such as
"
uptake, retention or stimulation-induced release of neurotransmitter.
Also, very recently it has been found that diazepam, in a dose
dependent manner, inhibited the post-tetanic potentiation of the
excitatory post-synapt i c potential in sympathetic ganglia (Suria,
1974). Further evidence indicated that the action is mediated by
prostaglandins of the E series (PGE^ and PGE2). Thus, it is con-
ceivable that the reduction in SIA induced by CDP may be due to
altered nerve impulse traffic or prostag I and in-mediated changes in
membrane potentials or ion flow, and therefore the manipulation of
various neurotransmitters would not effectively antagonize the
drug's action.
PART
A third reliable method of inducing aggressive behavior In
rats In the laboratory is to bilaterally lesion the septal area of
the brain. The Increased reactivity or hyperl rrl tab i I I ty reaction
toward Inanimate stimuli, auditory or tactual stimulation is well
known (Brady and Nauta, 1953). A number of experimenters have
tried to alter the aggressive behavior Induced by septal leslon-
ing with various pharmacologic agents including various depressant
drugs (Stark and Henderson, 1966), ant 1
-depressants (Horovitz
et a I., 1963) as well as minor tranquilizers such as CDP (Christmas
and Maxwell, 1969). However, their results have been varied and
contradictory. For instance, in at least one case, CDP was found
to selectively reduce septal lesion- Induced rage (SIR) (Christmas
and Maxwell, 1969) while others report a decrease In SIR only at
doses that produce ataxia (Sofia, 1969; Horovitz et al., 1963).
The discrepancies In these results can be explained by some of the
factors discussed earlier. However, the significance of behavioral
depression and the various measures used by these experimenters
to determine behavioral depression once again seems to be the most
important factor In their different results.
An effective way to determine the Importance of behavioral de-
pression as well as to compare the role of NE and 5HT turnover in
reducing septal rage is to use again chronic administration of CDP
and repeated testing so that tolerance to the adrenerglcal ly med-
iated behavioral depressant effect would develop. If after such
prolonged treatment, the same dose of CDP on the aggression test
day (post-lesion) still reduced septal rage, it would indicate that
the attenuation of SIR by CDP was not due to behavioral depression
but more I i ke
I y wou I d be due to the reduced turnover of 5HT which
persists throughout the chronic administration.
Method
The subjects were 27 male, albino Sprague-Daw ley rats weighing
between 360-450 grams at the start of the experiment. The animals
were maintained on a 12 hour alternating light-dark cycle with
light from 4:00 A.M. to 4:00 P.M. throughout the experiment. Ten
days prior to surgery the animals were randomly divided into four
groups. Groups 1 and 2 were administered saline injections (0.9%
saline, 1 cc/kg) each day for 10 days while groups 3 and 4 were
given 25 mg/kg CDP i.p. for the same period of time. On the 11th
day the animals were given septal lesions, on the 12th day they were
allowed to recover in their home cages. On the 13th day irritabil-
ity scoring and drug tests began and continued for 3 days.
On the drug test days, each rat served as Its own control and
the series of tests were applied immediately before, i hour after
and 1 hour after the appropriate drug treatment. Groups 1 and 4
received saline Injections at this time, while groups 2 and 3 were
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administered 25 mg/Kg CDP i.p. The procedures are shown in Table 1.
Irritability was evaluated by a series of tests consisting of (1)
response to nose poke, (2) response to flank poke, (3) resistance
to capture, and 'A) amount of vocalization upon capture. Scoring
was based on a scale of 0 for no reaction to 3 for a very violent
reaction. Rats scoring less than 8 out of a possible 12 were not
used in the drug tests.
After 3 days of testing the rats were sacrificed with an over-
dose of Diabutal and perfused with saline and W% formalin. The
brains were removed and fixed in Formalin. Three of the brains
were embedded in sucrose-formalin. Frozen serial sections were
then made in a frontal plane at 80/c . Every second section was
mounted and included ^K<s full extent of the lesion. The tissue was
stained with cresyl violet. Because of the delicate nature of the
tissue the remaining brains were embedded in gelatin and frozen
sections were made. The lesion size was determined visually by
two independent observers.
Results and Discussion
Out of 29 rats, 11 had almost total destruction of the medial
and lateral septal nuclei. Ten more had over 80% destruction, while
two showed only 50-75? destruction. Two of the 29 rats had less
than 50% destruction but these had been eliminated from the analysis
very early because of their low rage scores. For 4 rats the damage
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PRO. IP
PRETREATMENT LESION DRUG TESTSG OUP DAYS 1-10. DAY 11 DAYS l2-{5
saline lesion
saline lesion
CDP
S3 li ne
CDP
lesion CDP
CDP lesion saline
Table 1. Summary of procedures for pretreatment
,
septal lesioning and
post-lesioning drug test days for four groups.
was Indeterminate since the rats died and the brains had not been
perfused. Consequently the tissue was very fragile producing
poor histology.
There were a number of additional problems in determining
the extent of the lesion. First of all, since the objective of
making lesions was to destroy as much of the septum as possible,
there was the danger that a number of adjoining structures were
also destroyed. These structures might include the anterior com-
missure, nucleus acumbens septi
, bed nucleus of the anterior
commissure, corpus callosum and hippocampal commissure. However,
since the septal nuclei are bounded laterally by the lateral
ventricles, dorsal ly by the corpus callosum, and ventral ly by the
anterior commissure, there Is a natural boundary which seems to
keep the lesion within bounds.
Second, since there was a very short interval between lesion-
Ing and necropsy, gliosis was not well advanced, again making
lesion determinants difficult especially in ragged tissue. It
was not known whether the missing tissue was effectively lesloned
or merely torn away and lost during tissue preparation.
A within and between subjects analysis of variance was used
to examine the groups that were administered saline on days 13-15
(groups 1 and 4) as compared to those which received CDP on those
days (groups 2 and 3). The results are illustrated In Fig. 6.
A significant main effect for Groups indicated that treatment
with CDP reliably reduced SIR (F= 27.04, p<.001).
A significant Trials effect ( F= 175.67, p<.001) and a Groups
X Trials Interaction (F= 58.67, p<:.001) demonstrate that not only
were pre-drug scores different from post-drug scores for the groups,
but also that the post-drug reduction in rage for the CDP-treated
groups were different from the saline-treated groups. Fig. 6
clearly shows that rage scores after receiving CDP are significant-
ly lower than pre-drug scores, and those of saline controls.
The significant Days main effect ( F= 12.59, p^.001) in com-
bination with a lack of a signficant Groups x Days interaction sug-
gests that there was some reduction in rage over days of testing
but it was not a function of group. This gradual disappearance of
the rage reaction in septal rats has been well documented (Brady
and Nauta, 1955) and has been shown to be a function of time as
well as amount of handling (Gotsick and Marshall, 1972). No
Groups X Days x Trials interaction was detected.
A Student-t test comparing the first post- lesion pre-drug rage
score of groups 3 and 4, who were treated with CDP before lesion-
ing, with groups 1 and 2 who were treated with saline before lesion-
fng showed no significant difference between the two. This com-
parison was considered of importance because it has been recently
shown that certain presurgical drug treatments modify the recovery
period that follows neurological damage including that of septal
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I ca-
lesions (Harrell and Balagura, 1974). It is Interesting that in
the case of CDP treatment preceding septal lesioning, no modif
tlon of the lesion-induced rage could be found.
Now that it was demonstrated that CDP does significantly re-
duce SIR, a second analysis of variance compared the results of
groups 2 and 3 which were treated with CDP after lesioning but
which were treated differentially with CDP or saline before lesion-
ing. The results are illustrated in Fig. 7. There was no signif-
icant difference between these groups indicating that the differ-
ence in pre-lesion drug treatment did not have an effect on the
CDP- Induced post- les ion reduction of rage scores.
There was a significant Trials effect (F= 159.83, p<.001)
reflecting the reduction in rage scores after drug treatment,
but the lack of a Groups x Trials interaction suggests that the
rage is diminished by the drug treatment in the same way regard-
less of pre-lesion drug treatment. From this it can be concluded
that CDP is effective in reducing SIR in rats even after tolerance
to the behavioral depressant effect has developed. Thus, behavioral
depression is not likely to be a significant factor in the suppres-
sion of septal rage.
The significant Days main effect for Groups 2 and 3 indicated
a change in rage over days of testing ( F= 16.93, p<.001). Since
the Groups x Days Interaction was insignificant, it can be assumed
that the groups decreased in rage over the three days of testing
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In a similar way. No interaction between Groups x Days x Trials
was detected indicating that the differences in pre- and post-drug
rage scores for each group changed similarly over the three days
of testing.
It is interesting to note in Fig. 7 that while the post-drug
rage scores of the saline/CDP animals decline on the second day,
as compared to the first, on the third day there is a slight return
toward levels comparable to day 1. The CDP/CDP animals, however,
show cj more consistant trend toward lower rage scores over each
of the thnee days of testing. Even though these differences were
statistically insignificant they occur in an expected direction.
The general downward trend in rage scores in the CDP/CDP animals
probably is a reflection of the typical habituation that septal
rats show to rage provoking stimuli (Brady and Nauta, 1955). In
the case of the saline/CDP animals the increase in septal rage
wrth repeated testing might be expected to occur as tolerance to
the depressive effect of CDP developed. Meanwhile, this increase
in rage would be antagonized by the hab+tuation to the noxious
stimuli. The figure suggests that by the third day these two
effects canceled each other, leading to virtually identical post-
drug rage scores for the CDP/CDP and saline/CDP groups.
An additional point to be considered is the neurochemical
basis for the attenuation of SIR by CDP. Although the septal
syndrome is well known, the neurochemical correlates of SIR
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have not yet been determined. It has been shown that septal lesions
significantly decrease whole brain levels of 5HT while causing an
insignificani decrease in whole brain NE levels (Heller, Harvey
and Moore, 1962; Lints and Harvey, 1969). However, Dominguez and
Longo (1970) found that depletion of 5HT with pCPA produced an im-
mediate taming of septal animals. Harrell and Balagura (1974)
found that serotonergic depletion Induced by pCPA administration
for 5 days before lesioning, also reduced the post-lesion rage re-
sponse to various stimuli. Finally our CDP-induced attenuation of
SIR after chronic treatment with CDP indicates that reduced ad-
renergic activity is probably not responsible for the reductron in
rage and suggests that the persistent reduction in 5HT turnover may
be the effect responsible for the behavioral change. In each case,
however, it is difficult to explain how serotonergic depletion or
Inactivity could act in suppressing the rage when studies have
shown that 5HT reduction Is not correlated with septal irritability
(Heller, Harvey and Moore, 1962).
However, one must also be aware of the fact tnat measures of
whole brain 5HT do not reflect regional activity. Further, the
lesion might not only differentially alter serotonergic activity
but the drugs that were tested might also Interact in a selective
manner at various serotonergic centers. Evidence for the latter
effect has recently been presented. Harvey and Gal (1974) found
that pCPA causes a depletion of tryptophan hydroxylase, the enzyme
that converts tryptophan to 5HTP, but this effect was found in all
areas of the telencephalon except the septum.
Finally, it is interesting to note that CDP has a somewhat
paradoxical effect in terms of septal les Ion- I nduced behaviors.
Feldman et al. (1973) have found that CDP enhances the disinhibi-
tory effects of septal lesions in rats In an appraoch-avoi dance con-
flict as measured by reduced response latency; while in contrast,
the present experiment has shown an attenuation of septal hyper-
Irrltabillty by CDP. In regards to the ant 1
-aggress i on effect, it
Is possible that the effect is mediated via the amygdala since
Intracranial administration of diazepam in the amygdaloid complex
has been reported to eliminate the aggression induced by hypothal-
amic carbachol injection (Nagy and Desci
, 1973). It is quite clear
that much more research on the neurochemical correlates of septal
rage is necessary. It also appears that the regional specificity
of action of CDP within the central nervous system needs greater
clarification with respect to its behavioral correlates.
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Summary
In summary It can be said that three major conrrbutions have
been made by this research. First, CDP clearly has differential
effects on several aggressive behaviors. Our experiments have lent
support to the hypothesis that "aggression" is not a global con-
cept but consists of a variety of different behaviors with dis-
tinct physiological, anatomical and neurochemical substrates
(Moyer, 1968).
Second, the paradigm employed has, for the first time, pco-
vlded a means of determining the contribution of behavioral de-
pression to the reduction of aggressive behaviors. This is sig-
nificant because earlier discrepancies In the literature stemmed
from Inconsistant results In determining locomotor Impairment
because diverse measures of ataxia that were completely unrelated
to the aggression paradigm were used. It is clear that adrenergic-
ally mediated behavioral depression is instrumental in the CDP-
Induced suppression of muriclde in rats but not a significant fac-
tor In the suppression of shock- i nduced aggression or septal rage.
Finally, an examination of the possible role of serotonin or
cyclic nucleotides in the reduction of SIA by CDP was found to be
Indeterminate by manipulating the levels of serotonin and cAMP.
It suggests the possibility that these agents are not cental to
the anti-aggression properties of CDP. However, it is to be noted
that we have deliberately refrained from assuming a direct rela-
tionship between the anti-anxiety or disinhibitory effects of
CDP and the reduction of SIA. Since manipulating 5HT and cAMP was
ineffective, such a distinction seems warranted. Thus there is
the possibility that specific anti-aggression properties independ-
ent of the other effects exist and can be more completely speci-
fied by further research.
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